Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 9 de 9
Filtrar
Mais filtros

Base de dados
Tipo de documento
Intervalo de ano de publicação
1.
Eur J Immunol ; 42(11): 2881-8, 2012 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-22865279

RESUMO

Galectin-1 (Gal-1) is a member of a family of endogenous ß-galactose-binding proteins with a role in preventing autoimmune diseases and chronic inflammation. In this study, the involvement of Gal-1 in graft rejection was investigated by using Gal-1-deficient mice (Gal-1⁻/⁻). We demonstrate that in the absence of Gal-1, skin grafts are rejected earlier compared with those of WT mice, and that this is due to the role played by CD8⁺ T cells in graft rejection. The difference in graft survival observed between Gal-1⁻/⁻ and WT mice was explained by both an increase in the percentage of antigen-specific CD8+ T cells and by preferential secretion of IFN-γ and IL-17 by CD8⁺ T cells in Gal-1⁻/⁻ mice compared with WT mice. This study suggests that endogenous expression of Gal-1 contributes to graft survival. The results obtained from the use of mice deficient in Gal-1 also confirm a key role for CD8⁺ T cells in graft rejection.


Assuntos
Linfócitos T CD8-Positivos/imunologia , Galectina 1/imunologia , Rejeição de Enxerto/imunologia , Transplante de Pele/imunologia , Animais , Feminino , Citometria de Fluxo , Interferon gama/imunologia , Interleucina-17/imunologia , Linfonodos/imunologia , Masculino , Camundongos , Camundongos Endogâmicos C57BL , Camundongos Knockout , Organismos Livres de Patógenos Específicos , Baço/imunologia
2.
Dev Growth Differ ; 51(7): 607-15, 2009 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-19712265

RESUMO

Galectin1, the prototype member of a family of carbohydrate binding proteins, is involved in muscle stem cell behavior and in tissue regeneration after muscle injury in adult mice. Here, we addressed the question of when this gene is first acting in the muscle lineage. We found that Galectin1 is an early marker of myogenesis as the transcripts and protein are initially confined to the somites, starting from day 9.0 of embryogenesis. We next investigated its relationship with the muscle determination factors, Myf5 and Myod. By comparing the spatio-temporal distribution of Galectin1 transcripts in control and Myf5 null mutant embryos, we were able to establish that it acts downstream of Myf5. However, early myogenesis does not seem affected in Galectin1 null mutant embryos indicating that, unlike in the adult, Galectin1 does not play a role in muscle fate acquisition during development.


Assuntos
Embrião de Mamíferos/metabolismo , Galectina 1/genética , Regulação da Expressão Gênica no Desenvolvimento , Desenvolvimento Muscular , Animais , Biomarcadores , Linhagem da Célula , Desmina/metabolismo , Embrião de Mamíferos/citologia , Galectina 1/metabolismo , Camundongos , Camundongos Knockout , Fator Regulador Miogênico 5/deficiência , Fator Regulador Miogênico 5/genética , Miogenina/metabolismo
3.
Mol Cell Biol ; 23(13): 4637-48, 2003 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-12808103

RESUMO

Genetic studies have shown that retinoic acid (RA) signaling is required for mouse retina development, controlled in part by an RA-generating aldehyde dehydrogenase encoded by Aldh1a2 (Raldh2) expressed transiently in the optic vesicles. We examined the function of a related gene, Aldh1a1 (Raldh1), expressed throughout development in the dorsal retina. Raldh1(-/-) mice are viable and exhibit apparently normal retinal morphology despite a complete absence of Raldh1 protein in the dorsal neural retina. RA signaling in the optic cup, detected by using a RARE-lacZ transgene, is not significantly altered in Raldh1(-/-) embryos at embryonic day 10.5, possibly due to normal expression of Aldh1a3 (Raldh3) in dorsal retinal pigment epithelium and ventral neural retina. However, at E16.5 when Raldh3 is expressed ventrally but not dorsally, Raldh1(-/-) embryos lack RARE-lacZ expression in the dorsal retina and its retinocollicular axonal projections, whereas normal RARE-lacZ expression is detected in the ventral retina and its axonal projections. Retrograde labeling of adult Raldh1(-/-) retinal ganglion cells indicated that dorsal retinal axons project to the superior colliculus, and electroretinography revealed no defect of adult visual function, suggesting that dorsal RA signaling is unnecessary for retinal ganglion cell axonal outgrowth. We observed that RA synthesis in liver of Raldh1(-/-) mice was greatly reduced, thus showing that Raldh1 indeed participates in RA synthesis in vivo. Our findings suggest that RA signaling may be necessary only during early stages of retina development and that if RA synthesis is needed in dorsal retina, it is catalyzed by multiple enzymes, including Raldh1.


Assuntos
Aldeído Oxirredutases/genética , Aldeído Oxirredutases/fisiologia , Retina/metabolismo , Tretinoína/metabolismo , Animais , Southern Blotting , Cromatografia Líquida de Alta Pressão , Eletrorretinografia , Éxons , Genótipo , Heterozigoto , Imuno-Histoquímica , Hibridização In Situ , Fígado/metabolismo , Camundongos , Camundongos Endogâmicos C57BL , Camundongos Mutantes , Camundongos Transgênicos , Modelos Genéticos , Retina/citologia , Retina/embriologia , Retinal Desidrogenase , Transdução de Sinais , Fatores de Tempo , Transgenes
4.
Cancer Res ; 70(15): 6216-24, 2010 Aug 01.
Artigo em Inglês | MEDLINE | ID: mdl-20647324

RESUMO

Tumor angiogenesis is a key event in cancer progression. Here, we report that tumors can stimulate tumor angiogenesis by secretion of galectin-1. Tumor growth and tumor angiogenesis of different tumor models are hampered in galectin-1-null (gal-1(-/-)) mice. However, tumor angiogenesis is less affected when tumor cells express and secrete high levels of galectin-1. Furthermore, tumor endothelial cells in gal-1(-/-) mice take up galectin-1 that is secreted by tumor cells. Uptake of galectin-1 by cultured endothelial cells specifically promotes H-Ras signaling to the Raf/mitogen-activated protein kinase/extracellular signal-regulated kinase (Erk) kinase (Mek)/Erk cascade and stimulates endothelial cell proliferation and migration. Moreover, the activation can be blocked by galectin-1 inhibition as evidenced by hampered membrane translocation of H-Ras.GTP and impaired Raf/Mek/Erk phosphorylation after treatment with the galectin-1-targeting angiogenesis inhibitor anginex. Altogether, these data identify galectin-1 as a proangiogenic factor. These findings have direct implications for current efforts on galectin-1-targeted cancer therapies.


Assuntos
Galectina 1/fisiologia , Melanoma Experimental/irrigação sanguínea , Teratocarcinoma/irrigação sanguínea , Animais , Células Cultivadas , Embrião de Galinha , Membrana Corioalantoide/irrigação sanguínea , Células Endoteliais/citologia , Células Endoteliais/efeitos dos fármacos , Galectina 1/deficiência , Galectina 1/metabolismo , Galectina 1/farmacologia , Humanos , Sistema de Sinalização das MAP Quinases , Melanoma Experimental/metabolismo , Camundongos , Camundongos Endogâmicos C57BL , Camundongos Transgênicos , Proteínas Quinases Ativadas por Mitógeno/metabolismo , Neovascularização Patológica/patologia , Neovascularização Fisiológica/efeitos dos fármacos , Neovascularização Fisiológica/fisiologia , Proteínas Recombinantes/farmacologia , Teratocarcinoma/metabolismo , Proteínas ras/metabolismo
5.
Dev Dyn ; 236(4): 1014-24, 2007 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-17366633

RESUMO

Galectin-1 has been implicated in the development of skeletal muscle, being maximally expressed at the time of myofiber formation. Furthermore, in the presence of exogenous galectin-1, mononuclear myoblasts show increased fusion in vitro. In the current study, we have used the galectin-1 null mouse to elucidate the role of galectin-1 in skeletal muscle development and regeneration. Myoblasts derived from the galectin-1 mutant showed a reduced ability to fuse in vitro. In galectin-1 null mutants, there was evidence of a delay in muscle fiber development at the neonatal stage and muscle fiber diameter was reduced when compared with wild-type at the adult stage. Muscle regeneration was also compromised in the galectin-1 mutant with the process being delayed and a reduced fiber size being maintained. These results, therefore, show a definitive role for galectin-1 in fusion of myoblasts both in vitro, in vivo, and in regeneration after recovery from induced injury.


Assuntos
Fusão Celular , Galectina 1/genética , Músculo Esquelético/fisiologia , Mioblastos Esqueléticos/fisiologia , Regeneração/genética , Animais , Animais Recém-Nascidos , Células Cultivadas , Camundongos , Camundongos Endogâmicos , Camundongos Knockout , Desenvolvimento Muscular/genética , Fibras Musculares Esqueléticas/citologia , Mioblastos Esqueléticos/citologia
6.
Transgenic Res ; 13(5): 463-73, 2004 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-15587270

RESUMO

We report here knock-in of diphteria toxin A chain (dta) gene at the Ins2 locus, using the strategy previously employed to insert lacZ under control of the Ins2 promoter. Mutant Ins2(dta/+), Ins2(dta/lacZ) or Ins2(lacZ/+) mouse pups were generated by breeding and analyzed to study the effects of toxigenetic beta-cell ablation on islet development and to localize the extrapancreatic Ins2 expression site in the brain. Ins2(dta/+) and Ins2(dta/lacZ) pups developed a severe diabetic ketoacidosis and died rapidly. Histological analysis of their pancreas revealed that beta-cells completely disappeared in their islets as evidenced by loss of lacZ activity or insulin immunonostaining. beta-cell ablation did not alter the size of other islet cell populations which were normal at birth, although the glucagon-cell population was reduced by 85% at embryonic day E12.5. In the brain, comparative analysis of lacZ expression in Ins2(lacZ/+) and Ins2(dta/laZ) mice identified the choroid plexus (CP) as a major Ins2 expression site. This finding was confirmed by RT-PCR analysis of insulin transcripts in RNAs prepared from microdissected wild-type CP. Transcripts for other key beta-cell markers, with the notable exception of Pdx-1, were also found in CP RNAs. These results must revive interest in studies focused on extrapancreatic insulin gene expression.


Assuntos
Plexo Corióideo/metabolismo , Toxina Diftérica/genética , Regulação da Expressão Gênica no Desenvolvimento , Ilhotas Pancreáticas/metabolismo , Pâncreas/metabolismo , Fragmentos de Peptídeos/genética , Animais , Plexo Corióideo/patologia , Cetoacidose Diabética/metabolismo , Cetoacidose Diabética/patologia , Toxina Diftérica/metabolismo , Vetores Genéticos/genética , Insulina/metabolismo , Ilhotas Pancreáticas/patologia , Óperon Lac/genética , Camundongos , Camundongos Transgênicos , Pâncreas/patologia , Fragmentos de Peptídeos/metabolismo , Regiões Promotoras Genéticas
7.
J Biol Chem ; 277(16): 13804-11, 2002 Apr 19.
Artigo em Inglês | MEDLINE | ID: mdl-11836246

RESUMO

The ability of class I alcohol dehydrogenase (ADH1) and class IV alcohol dehydrogenase (ADH4) to metabolize retinol to retinoic acid is supported by genetic studies in mice carrying Adh1 or Adh4 gene disruptions. To differentiate the physiological roles of ADH1 and ADH4 in retinoid metabolism we report here the generation of an Adh1/4 double null mutant mouse and its comparison to single null mutants. We demonstrate that loss of both ADH1 and ADH4 does not have additive effects, either for production of retinoic acid needed for development or for retinol turnover to minimize toxicity. During gestational vitamin A deficiency Adh4 and Adh1/4 mutants exhibit completely penetrant postnatal lethality by day 15 and day 24, respectively, while 60% of Adh1 mutants survive to adulthood similar to wild-type. Following administration of a 50-mg/kg dose of retinol to examine retinol turnover, Adh1 and Adh1/4 mutants exhibit similar 10-fold decreases in retinoic acid production, whereas Adh4 mutants have only a slight decrease. LD(50) studies indicate a large increase in acute retinol toxicity for Adh1 mutants, a small increase for Adh4 mutants, and an intermediate increase for Adh1/4 mutants. Chronic retinol supplementation during gestation resulted in 65% postnatal lethality in Adh1 mutants, whereas only approximately 5% for Adh1/4 and Adh4 mutants. These studies indicate that ADH1 provides considerable protection against vitamin A toxicity, whereas ADH4 promotes survival during vitamin A deficiency, thus demonstrating largely non-overlapping functions for these enzymes in retinoid metabolism.


Assuntos
Álcool Desidrogenase/fisiologia , Deficiência de Vitamina A/genética , Vitamina A/toxicidade , Animais , Cromatografia Líquida de Alta Pressão , Feminino , Vetores Genéticos , Genótipo , Heterozigoto , Masculino , Camundongos , Camundongos Transgênicos , Modelos Genéticos , Mutação , Fatores de Tempo , Tretinoína/farmacologia , Vitamina A/sangue
8.
Proc Natl Acad Sci U S A ; 99(8): 5337-42, 2002 Apr 16.
Artigo em Inglês | MEDLINE | ID: mdl-11959987

RESUMO

Influence of vitamin A (retinol) on growth depends on its sequential oxidation to retinal and then to retinoic acid (RA), producing a ligand for RA receptors essential in development of specific tissues. Genetic studies have revealed that aldehyde dehydrogenases function as tissue-specific catalysts for oxidation of retinal to RA. However, enzymes catalyzing the first step of RA synthesis, oxidation of retinol to retinal, remain unclear because none of the present candidate enzymes have expression patterns that fully overlap with those of aldehyde dehydrogenases during development. Here, we provide genetic evidence that alcohol dehydrogenase (ADH) performs this function by demonstrating a role for Adh3, a ubiquitously expressed form. Adh3 null mutant mice exhibit reduced RA generation in vivo, growth deficiency that can be rescued by retinol supplementation, and completely penetrant postnatal lethality during vitamin A deficiency. ADH3 was also shown to have in vitro retinol oxidation activity. Unlike the second step, the first step of RA synthesis is not tissue-restricted because it is catalyzed by ADH3, a ubiquitous enzyme having an ancient origin.


Assuntos
Álcool Desidrogenase/biossíntese , Álcool Desidrogenase/metabolismo , Tretinoína/metabolismo , Álcool Desidrogenase/genética , Oxirredutases do Álcool/biossíntese , Animais , Citosol/enzimologia , Genótipo , Camundongos , Camundongos Transgênicos , Mutação , Oxigênio/metabolismo , Retinaldeído/metabolismo , Fatores de Tempo , Vitamina A/metabolismo , Vitamina A/farmacologia , Deficiência de Vitamina A/metabolismo
9.
Int J Exp Diabesity Res ; 4(1): 7-12, 2003.
Artigo em Inglês | MEDLINE | ID: mdl-12745665

RESUMO

The authors have derived a new beta-cell line (betaIns2(-/-lacZ)) from Ins2-/- mice that carry the lacZ reporter gene under control of the Ins2 promoter. betaIns2(-/-lacZ) cells stained positively using anti-insulin antibody, expressed beta-cell-specific genes encoding the transcription factor PDX-1, glucokinase, and Glut-2, retained glucose-responsiveness for insulin secretion, and expressed the lacZ gene. Analysis of Ins1 expression by reverse transcriptase-polymerase chain reaction (RT-PCR) showed that Ins1 transcripts were significantly raised to compensate for the lack of Ins2 transcripts in betaIns2(-/-lacZ) cells, as compared to those found in betaTC1 cells expressing both Ins1/Ins2. Thus, transcriptional up-regulation of the remaining functional insulin gene in Ins2-/- mice could potentially contribute to the beta-cell adaptation exhibited by these mutants, in addition to the increase in beta-cell mass that we previously reported. We have also shown that lacZ expression, as analyzed by determining beta-galactosidase activity, was up-regulated by incubating betaIns2(-/-lacZ) cells with GLP-1 and/or IBMX, 2 known stimulators of insulin gene expression. These cells thus represent a new tool for testing of molecules capable of stimulating Ins2 promoter activity.


Assuntos
Resistência à Insulina/genética , Insulina/deficiência , Animais , Sequência de Bases , Linhagem Celular , Cruzamentos Genéticos , Primers do DNA , Glucose/farmacologia , Imuno-Histoquímica , Insulina/genética , Insulina/metabolismo , Secreção de Insulina , Ilhotas Pancreáticas/efeitos dos fármacos , Ilhotas Pancreáticas/metabolismo , Camundongos , Camundongos Knockout , Camundongos Transgênicos , Reação em Cadeia da Polimerase Via Transcriptase Reversa , beta-Galactosidase/análise , beta-Galactosidase/genética
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA